Our research is centered on bioprocess understanding for the advancement of cell technologies. We focus on novel therapies and complex biopharmaceuticals, namely vaccines, viral vectors and cells for gene and cell-based therapies. Ongoing projects include the development and application of omics tools for bioprocess understanding and product attributes characterization with emphasis on single-cell transcriptomics, and on bioprocess development for rAAV production.